The company's asset-to-be has two commercialized medicines on the market based on the same active ingredient.

EMPAVELI®(pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in CanadaApproval supported ...

Ilene C. Wetiz, MD, professor of clinical medicine at the Keck School of Medicine at the University of Southern California, discusses the baseline characteristics of the case: So, case three is ...

Bringing together Biogen and Apellis’ commercialization capabilities will maximize the potential of both EMPAVELI ® and SYFOVRE ®, while Apellis’ talent and expertise will accelerate Biogen’s entry ...

Biogen BIIB and Apellis Pharmaceuticals APLS announced a definitive agreement under which Biogen will acquire all outstanding ...

Most of us think of cars as a huge purchase. A reliable new vehicle can cost anywhere from $25,000 to $32,000. But what if a single dose of medicine costs even more than that? That's exactly the ...

Welcome to the Paroxysmal Nocturnal Hemoglobinuria (PNH) Clinical Case Review, a series of case presentations by an expert in the field of PNH. In this video, Ilene C. Wetiz, MD, professor of clinical ...

SBio Inc. (01530.HK) today released its 2025 annual results announcement. Fueled by the dual core engines of breakthroughs in innovative R&D and strategic global collaboration, the company delivered a ...

That gnarly old buck just lays there, chewing his cud and wasting the day. Then, about 20 minutes after nightfall, he rises, stretches, and departs for distant fields. As a result, this buck is never ...

Orthopnea means you have shortness of breath when you lie down that goes away as you sit or stand up. It usually comes on over time, but sometimes it can happen all of a sudden. Orthopnea is a sign of ...